RxSight, Inc. Common Stock RXST
i
Market dataready · fetched 2026-11-07T05:45:28.358Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-12-18
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-06T21:00:00.941997741Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-07T05:45:27.491102+00:00
RxSight, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | 5.33 | 405.2% | 46.2% | |||
| 35Δ | 5.74 | 384.2% | 42.3% | |||
| 40Δ | 6.16 | 363.2% | 38.4% | |||
| 45Δ | 6.57 | 342.2% | 34.5% | |||
| 50Δ | 6.98 | 321.1% | 30.5% | |||
| 55Δ | 7.40 | 300.1% | 26.6% | |||
| 60Δ | 7.81 | 279.1% | 22.7% | |||
| 65Δ | 5.83 | 386.4% | 70.2% | 8.23 | 258.0% | 18.8% |
| 70Δ | 5.46 | 418.0% | 67.4% | 8.64 | 237.0% | 14.9% |
| 75Δ | 5.09 | 449.6% | 64.7% | 9.05 | 216.0% | 10.9% |
| 80Δ | 4.11 | 388.4% | 44.7% | 9.47 | 195.0% | 7.0% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.33
- IV
- 405.2%
- B/E move
- 46.2%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.74
- IV
- 384.2%
- B/E move
- 42.3%
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.16
- IV
- 363.2%
- B/E move
- 38.4%
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.57
- IV
- 342.2%
- B/E move
- 34.5%
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.98
- IV
- 321.1%
- B/E move
- 30.5%
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 7.40
- IV
- 300.1%
- B/E move
- 26.6%
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 7.81
- IV
- 279.1%
- B/E move
- 22.7%
65Δ
- Pseudo strike
- 5.83
- IV
- 386.4%
- B/E move
- 70.2%
- Pseudo strike
- 8.23
- IV
- 258.0%
- B/E move
- 18.8%
70Δ
- Pseudo strike
- 5.46
- IV
- 418.0%
- B/E move
- 67.4%
- Pseudo strike
- 8.64
- IV
- 237.0%
- B/E move
- 14.9%
75Δ
- Pseudo strike
- 5.09
- IV
- 449.6%
- B/E move
- 64.7%
- Pseudo strike
- 9.05
- IV
- 216.0%
- B/E move
- 10.9%
80Δ
- Pseudo strike
- 4.11
- IV
- 388.4%
- B/E move
- 44.7%
- Pseudo strike
- 9.47
- IV
- 195.0%
- B/E move
- 7.0%
Options history
No recorded observations
Medical Devices
SENS
Senseonics Holdings, Inc., a medical technology company, develops and markets continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe,…
More →SGHT
Sight Sciences Inc. (SGHT) is an innovative medical technology company specializing in the advancement of treatments for ocular diseases, with a particular emphasis on glaucoma…
More →SIBN
SI-BONE, Inc., a medical device company, develops implantable devices used in the surgical treatment of the sacropelvic anatomy in the United States and internationally. The…
More →SNN
Smith & Nephew plc develops, manufactures, markets and sells medical devices worldwide. The company is headquartered in Watford, the United Kingdom.
More →SRTS
Sensus Healthcare, Inc. manufactures, distributes and markets superficial radiation therapy devices to healthcare providers worldwide. The company is headquartered in Boca Raton,…
More →STE
Description unavailable
More →